Linezolid for treatment of subdural empyema due to Streptococcus: case reports

Surgical Neurology

Volumn 71, Issue 1, 2009, Pages 89-91

  Lefebvre, Laurent ^a   Metellus, Philippe ^a   Dufour, Henry ^a   Bruder, Nicolas ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Linezolid; Neurosurgical; Sepsis; Streptococcus; Subdural empyema

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; HEPARIN; LINEZOLID; METRONIDAZOLE; PHENYTOIN; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; PHYSIOTHERAPY; SEIZURE; STREPTOCOCCUS CONSTELLATUS; SUBDURAL EMPYEMA; SURGICAL DRAINAGE; TREATMENT RESPONSE;

ACETAMIDES; ADOLESCENT; ANTI-BACTERIAL AGENTS; BRAIN NEOPLASMS; DRAINAGE; EMPYEMA, SUBDURAL; FACIAL INJURIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYDRIASIS; NEUROSURGICAL PROCEDURES; OXAZOLIDINONES; PARESIS; SEIZURES; STREPTOCOCCAL INFECTIONS; SUBDURAL SPACE; VANCOMYCIN;

EID: 57249100564     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.06.083     Document Type: Article

References (13)

1. Bressler A.M., Zimmer S.M., Gilmore J.L., and Somani J. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 4 (2004) 528-531
2. Dill S.R., Cobbs C.G., and McDonald C.K. Subdural empyema: analysis of 32 cases and review. Clin Infect Dis 20 (1995) 372-386
3. French G. Safety and tolerability of linezolid. J Antimicrob Chemother 51 Suppl 2 (2003) ii45-ii53
4. Hartman B., Helfgott D., and Weingarten K. Subdural empyema and suppurative intracranial phlebitis. In: Scheld W.M., Whitley R., and Marra C. (Eds). Infections of the central nervous system (2004), Lippincott Williams & Wilkins, Philadelphia 523-535
5. Krueger W.A., Kottler B., Will B.E., et al. Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid. J Clin Microbiol 42 (2004) 929-932
6. Lovering A.M., Zhang J., Bannister G.C., et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 50 (2002) 73-77
7. McCollum M., Rhew D.C., and Parodi S. Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species. Clin Ther 25 (2003) 3173-3189
8. Nathoo N., Nadvi S.S., van Dellen J.R., and Gouws E. Intracranial subdural empyemas in the era of computed tomography: a review of 699 cases. Neurosurgery 44 (1999) 529-535
9. Rupprecht T.A., and Pfister H.W. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol 12 (2005) 536-542
10. Shaikh Z.H., Peloquin C.A., and Ericsson C.D. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 33 (2001) 375-379
11. Soriano A., Miro O., and Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med 353 (2005) 2305-2306
12. Viale P., Pagani L., Cristini F., et al. Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 34 (2002) 456-459
13. Villani P., Regazzi M.B., Marubbi F., et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 46 (2002) 936-937